Ceribell (CBLL) Non-Current Deffered Revenue (2023 - 2025)
Ceribell (CBLL) posted Non-Current Deffered Revenue of $3000.0 for Q3 2025, down 57.14% on a QoQ basis from $7000.0 in Q2 2025, and down 90.91% year-over-year from $33000.0 in Q3 2024.
Ceribell (CBLL) Non-Current Deffered Revenue (2023 - 2025) Analysis & Trends
Ceribell's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $3000.0 for Q3 2025.
- Quarterly Non-Current Deffered Revenue fell 90.91% year-over-year to $3000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3000.0 (down 90.91% YoY) and the FY2024 annual result came in at $30000.0, down 31.82% from the prior year.
- Non-Current Deffered Revenue was $3000.0 for Q3 2025 at Ceribell, down from $7000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $44000.0 in Q4 2023 and bottomed at $3000.0 in Q3 2025.
- A 3-year average of $21500.0 and a median of $21000.0 in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue plunged 31.82% — and 2025, when it tumbled 90.91%.
- Ceribell's Non-Current Deffered Revenue stood at $44000.0 in 2023, then tumbled by 31.82% to $30000.0 in 2024, then tumbled by 90.0% to $3000.0 in 2025.
- Business Quant data shows CBLL's Non-Current Deffered Revenue at $3000.0 in Q3 2025, $7000.0 in Q2 2025, and $12000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Dec 31, 2023 | 44,000.00 |